Latest Advances

  • Condition: Cutaneous Melanoma Metastases and Rare Non-Melanoma Skin Cancer
  • Journal: Anticancer research
  • Treatment Used: Electrochemotherapy
  • Number of Patients: 68
  • Published —
This study tested the safety and efficacy of using electrochemotherapy to treat patients with cutaneous melanoma metastases and rare non-melanoma skin cancer.
  • Condition: Advanced Skin Cancer with Concomitant Hematological Malignancy
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Immune Checkpoint Inhibition Therapy
  • Number of Patients: 84
  • Published —
This study tested the safety and efficacy of using immune checkpoint inhibition therapy to treat patients with advanced skin cancer and concomitant hematological malignancy.
  • Condition: Metastatic Merkel Cell Carcinoma (mMCC)
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Immune Checkpoint Inhibitors (ICIs)
  • Number of Patients: 23
  • Published —
This study evaluated the effectiveness and safety of immune checkpoint inhibitors (stop the immune system from turning off before cancer is completely eliminated; ICIs) in patients with metastatic (has spread beyond the skin) Merkel cell carcinoma (rare and aggressive skin cancer; mMCC).
  • Condition: Merkel Cell Carcinoma (MCC) in the Netherlands
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab
  • Number of Patients: 54
  • Published —
This study reported the effectiveness and toxicity of avelumab in patients with merkel cell carcinoma.
  • Condition: Merkel Cell Carcinoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab and N-803 with Abraxane
  • Number of Patients: 1
  • Published —
In this study, researchers evaluated the outcomes of treating Merkel cell carcinoma with avelumab, N-803, and abraxane.
  • Condition: Merkel Cell Carcinoma
  • Journal: Medical science monitor : international medical journal of experimental and clinical research
  • Treatment Used: Lymph Node Surgery
  • Number of Patients: 1973
  • Published —
This study investigated the clinical outcomes and prognosis of patients with Merkel Cell Carcinoma.
  • Condition: Merkel Cell Carcinoma
  • Journal: Cirugia y cirujanos
  • Treatment Used: Surgery
  • Number of Patients: 0
  • Published —
The study researched the outcomes of Merkel cell carcinoma.
  • Condition: Merkel Cell Carcinoma
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Treatment Used: Neoadjuvant Checkpoint Inhibitor Therapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with Merkel Cell Carcinoma.
  • Condition: Patients with Previously Treated Metastatic Merkel Cell Carcinoma (MCC)
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab
  • Number of Patients: 88
  • Published —
This study reported the long-term safety and effectiveness of avelumab in patients with Merkel cell carcinoma (MCC).
  • Condition: Localized Merkel Cell Carcinoma
  • Journal: Journal of medical imaging and radiation oncology
  • Treatment Used: Radiotherapy
  • Number of Patients: 2304
  • Published —
The study researched the outcomes of radiotherapy in treating localized Merkel cell carcinoma.
  • Condition: Merkel Cell Carcinoma
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Treatment Used: Nivolumab
  • Number of Patients: 39
  • Published —
In this study, researchers evaluated the outcomes of administering nivolumab for the treatment of Merkel cell carcinoma.
  • Condition: Metastatic Merkel Cell Carcinoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab
  • Number of Patients: 240
  • Published —
In this study, researchers evaluated the safety and effectiveness of avelumab for the treatment of metastatic Merkel cell carcinoma.
Showing 1-12 of 40